药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxybuprocaine
Thioproperazine
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Thioproperazine.
Oxybuprocaine
Acepromazine
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Acepromazine.
Oxybuprocaine
Periciazine
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Periciazine.
Oxybuprocaine
Methotrimeprazine
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Methotrimeprazine.
Oxybuprocaine
Aripiprazole
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Aripiprazole.
Oxybuprocaine
Levomilnacipran
Levomilnacipran may increase the tachycardic activities of Ephedrine.
Oxybuprocaine
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Ephedrine.
Oxybuprocaine
Milnacipran
Milnacipran may increase the tachycardic activities of Ephedrine.
Oxybuprocaine
Sibutramine
Sibutramine may increase the tachycardic activities of Ephedrine.
Oxybuprocaine
Metergoline
Metergoline may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Terguride
Terguride may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Dihydroergocryptine
Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Dihydroergocristine
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Dihydroergocornine
Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Lysergic acid diethylamide
Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Pergolide
Pergolide may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Ergoloid mesylate
Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ephedrine.
Oxybuprocaine
Iobenguane
Ephedrine can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxybuprocaine
PCS-499
The risk or severity of adverse effects can be increased when Ephedrine is combined with PCS-499.
Oxybuprocaine
8-chlorotheophylline
The risk or severity of adverse effects can be increased when Ephedrine is combined with 8-chlorotheophylline.